AUPS251502A0 - Protein kinase inhibitors - Google Patents

Protein kinase inhibitors

Info

Publication number
AUPS251502A0
AUPS251502A0 AUPS2515A AUPS251502A AUPS251502A0 AU PS251502 A0 AUPS251502 A0 AU PS251502A0 AU PS2515 A AUPS2515 A AU PS2515A AU PS251502 A AUPS251502 A AU PS251502A AU PS251502 A0 AUPS251502 A0 AU PS251502A0
Authority
AU
Australia
Prior art keywords
protein kinase
kinase inhibitors
inhibitors
protein
kinase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AUPS2515A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cytopia Pty Ltd
Original Assignee
Cytopia Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cytopia Pty Ltd filed Critical Cytopia Pty Ltd
Priority to AUPS2515A priority Critical patent/AUPS251502A0/en
Publication of AUPS251502A0 publication Critical patent/AUPS251502A0/en
Priority to CNB038117355A priority patent/CN100558715C/en
Priority to IL16526403A priority patent/IL165264A0/en
Priority to PCT/AU2003/000629 priority patent/WO2003099796A1/en
Priority to CA2486183A priority patent/CA2486183C/en
Priority to NZ537155A priority patent/NZ537155A/en
Priority to KR1020047018881A priority patent/KR101027426B1/en
Priority to DE60317198T priority patent/DE60317198T2/en
Priority to EP03727001A priority patent/EP1513821B1/en
Priority to GB0318438A priority patent/GB2392154B/en
Priority to JP2004507453A priority patent/JP4704032B2/en
Priority to AT03727001T priority patent/ATE377004T1/en
Priority to US10/469,303 priority patent/US7122550B2/en
Priority to AU2003232919A priority patent/AU2003232919B2/en
Priority to IL165264A priority patent/IL165264A/en
Priority to ZA200409341A priority patent/ZA200409341B/en
Priority to US11/367,248 priority patent/US20060148824A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D241/20—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AUPS2515A 2002-05-23 2002-05-23 Protein kinase inhibitors Abandoned AUPS251502A0 (en)

Priority Applications (17)

Application Number Priority Date Filing Date Title
AUPS2515A AUPS251502A0 (en) 2002-05-23 2002-05-23 Protein kinase inhibitors
AU2003232919A AU2003232919B2 (en) 2002-05-23 2003-05-23 Protein kinase inhibitors
EP03727001A EP1513821B1 (en) 2002-05-23 2003-05-23 Protein kinase inhibitors
JP2004507453A JP4704032B2 (en) 2002-05-23 2003-05-23 Protein kinase inhibitor
PCT/AU2003/000629 WO2003099796A1 (en) 2002-05-23 2003-05-23 Protein kinase inhibitors
CA2486183A CA2486183C (en) 2002-05-23 2003-05-23 Protein kinase inhibitors
NZ537155A NZ537155A (en) 2002-05-23 2003-05-23 Protein kinase inhibitors
KR1020047018881A KR101027426B1 (en) 2002-05-23 2003-05-23 Protein kinase inhibitors
DE60317198T DE60317198T2 (en) 2002-05-23 2003-05-23 PROTEIN KINASE INHIBITORS
CNB038117355A CN100558715C (en) 2002-05-23 2003-05-23 Kinases inhibitor
GB0318438A GB2392154B (en) 2002-05-23 2003-05-23 Protein Kinase Inhibitors
IL16526403A IL165264A0 (en) 2002-05-23 2003-05-23 Protein kinase inhibitors
AT03727001T ATE377004T1 (en) 2002-05-23 2003-05-23 PROTEIN KINASE INHIBITORS
US10/469,303 US7122550B2 (en) 2002-05-23 2003-05-23 Protein kinase inhibitors
IL165264A IL165264A (en) 2002-05-23 2004-11-16 Protein kinase inhibitors, pharmaceutical compositions comprising them and use thereof in the preparation of medicaments for treating protein kinase-associated diseases
ZA200409341A ZA200409341B (en) 2002-05-23 2004-11-19 Protein kinase inhibitors.
US11/367,248 US20060148824A1 (en) 2002-05-23 2006-03-02 Protein kinase inhibitors

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPS2515A AUPS251502A0 (en) 2002-05-23 2002-05-23 Protein kinase inhibitors

Publications (1)

Publication Number Publication Date
AUPS251502A0 true AUPS251502A0 (en) 2002-06-13

Family

ID=3836079

Family Applications (1)

Application Number Title Priority Date Filing Date
AUPS2515A Abandoned AUPS251502A0 (en) 2002-05-23 2002-05-23 Protein kinase inhibitors

Country Status (4)

Country Link
JP (1) JP4704032B2 (en)
KR (1) KR101027426B1 (en)
AU (1) AUPS251502A0 (en)
ZA (1) ZA200409341B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002953255A0 (en) * 2002-12-11 2003-01-02 Cytopia Research Pty Ltd Protein kinase inhibitors
NZ546057A (en) * 2003-12-03 2010-04-30 Ym Bioscience Australia Pty Lt Tubulin inhibitors
DK2848610T3 (en) * 2006-11-15 2017-11-06 Ym Biosciences Australia Pty Inhibitors of kinase activity
JP5562256B2 (en) * 2008-02-01 2014-07-30 アチニオン・ファーマスーティカルズ・アクチエボラーグ Novel compounds, their use and production
WO2013004332A1 (en) * 2011-07-07 2013-01-10 Merck Patent Gmbh Substituted azaheterocycles for the treatment of cancer
WO2014110198A2 (en) * 2013-01-10 2014-07-17 Zisman Lawrence S Therapeutic indications of kinase inhibitors
EP3007689B1 (en) * 2013-01-10 2018-03-07 Pulmokine, Inc. Non-selective kinase inhibitors
CN106132403B (en) * 2013-10-11 2020-04-28 普尔莫凯恩股份有限公司 Spray-dried formulations
CA3041679A1 (en) 2016-10-27 2018-05-03 Lawrence S. ZISMAN Combination therapy for treating pulmonary hypertension

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2423050A1 (en) * 2000-09-20 2002-03-28 Ortho-Mcneil Pharmaceutical, Inc. Pyrazine derivatives as modulators of tyrosine kinases

Also Published As

Publication number Publication date
KR101027426B1 (en) 2011-04-11
ZA200409341B (en) 2006-02-22
KR20050010010A (en) 2005-01-26
JP4704032B2 (en) 2011-06-15
JP2005535596A (en) 2005-11-24

Similar Documents

Publication Publication Date Title
AU2003249442A1 (en) Kinase inhibitors
AU2003222055A1 (en) Kinase inhibitors
AU2003254053A1 (en) Pyrazolopyrimidines as protein kinase inhibitors
AU2003299651A1 (en) Tyrosine kinase inhibitors
AU2003271566A1 (en) Pyrrolopyrazines as kinase inhibitors
AU2003265349A1 (en) Pyrrolotriazine kinase inhibitors
AU2003259749A1 (en) 3-pyrrolyl-pyridopyrazoles and 3-pyrrolyl-indazoles as novel kinase inhibitors
AU2003202263A1 (en) Roh-kinase inhibitors
EP1510210A4 (en) Immunity-related protein kinase inhibitors
IL208520A0 (en) Akt protein kinase inhibitors
AU2003282891A1 (en) Novel tyrosine kinases inhibitors
PL375447A1 (en) Protein kinase inhibitors and uses thereof
AU2002334355A1 (en) Protein tyrosine kinase inhibitors
IL173380A0 (en) Pyridinylamino-pyrimidine derivatives as protein kinase inhibitors
AU2003298942A1 (en) Tyrosine kinase inhibitors
SI1569907T1 (en) Nicotinamide-based kinase inhibitors
AU2002953255A0 (en) Protein kinase inhibitors
AU2003245555A1 (en) Sphingosine kinase inhibitors
AU2003237446A1 (en) Pyrazole-derivatives as p38 kinase inhibitors
AU2003275282A1 (en) Novel tyrosine kinase inhibitors
EP1558609A4 (en) Kinase inhibitors
AU2003254051A1 (en) Pyrazolopyrimidines as kinase inhibitors
AU2003249683A1 (en) Nf-:b inhibitors
AU2003261204A1 (en) Pyrazolopyrimidines as kinase inhibitors
AU2003220437A1 (en) Thiopyrimidine and isothiazolopyrimidine kinase inhibitors